Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/110383| Title: | Towards optimal cut-off trough levels of adalimumab and etanercept for a good therapeutic response in rheumatoid arthritis. Results of the INMUNOREMAR study |
| Author: | Sanmartí Sala, Raimon Inciarte-Mundo, Jose Estrada-Alarcon, Paula Garcia-Manrique, Maria Narváez García, Francisco Javier Rodríguez Moreno, Jesús Gomez-Centeno, Antoni Pascal i Capdevila, Mariona Yagüe, Jordi |
| Keywords: | Artritis reumatoide Medicaments Administració de medicaments Sistema immunològic Anticossos monoclonals Rheumatoid arthritis Drugs Administration of drugs Immune system Monoclonal antibodies |
| Issue Date: | Aug-2015 |
| Publisher: | BMJ Publishing Group |
| Abstract: | We read with great interest the paper by Chen et al1 analysing the relationship between therapeutic response to adalimumab and etanercept and serum drug trough levels in 70 patients with rheumatoid arthritis (RA). ... |
| Note: | Article en format correspondència |
| Note: | Reproducció del document publicat a: https://doi.org/10.1136/annrheumdis-2015-207530 |
| It is part of: | Annals of the Rheumatic Diseases, 2015, vol. 74, num. 8, p. e42 |
| URI: | http://hdl.handle.net/2445/110383 |
| Related resource: | https://doi.org/10.1136/annrheumdis-2015-207530 |
| ISSN: | 0003-4967 |
| Appears in Collections: | Articles publicats en revistes (Ciències Clíniques) |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| 657895.pdf | 411.63 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.